Companies / Tracon Pharmaceuticals, Inc.
Tracon Pharmaceuticals, Inc.
TCONCIK 1394319
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | Opaleye Management Inc. 10% owner | Sell Open-market sale | Common Stock, par value $0.001 per share | $1.27M | -4.3M -100.00% | 0 | medium |
| Jun 21, 2022 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $1.11M | +842K +28.69% | 3,776,589 | high |
| Mar 9, 2023 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $240.8K | +175K +4.21% | 4,324,508 | medium |
| Dec 27, 2021 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $219.1K | +75K +2.98% | 2,592,371 | medium |
| Dec 3, 2021 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $183.6K | +80K +3.41% | 2,428,371 | medium |
| Dec 14, 2022 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $175.8K | +140K +3.49% | 4,150,000 | medium |
| Nov 10, 2023 | Opaleye Management Inc. 10% owner | Sell Open-market sale | Common Stock, par value $0.001 per share | $129.4K | -440K -100.00% | 0 | medium |
| Dec 1, 2021 | Opaleye Management Inc. 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $108.1K | +45K +1.96% | 2,338,371 | medium |